Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The purpose of current study is to evaluate the efficacy and safety of hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumors.
Epistemonikos ID: 0d6ce3e27ec6fddc1a9dd7a6c244a94307399669
First added on: Feb 19, 2024